Stage IV Salivary Gland Cancer Completed Phase 1 Trials for Filgrastim (DB00099)

Also known as: Salivary gland cancer stage IV / Metastatic salivary gland cancer / Malignant salivary gland cancer stage IV

DBCOND0028780 (Stage IV Salivary Gland Cancer)Completed1 IdentifierTitlePurposeDrugs
NCT00023959Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck CancerTreatment